Ultsch, B., Damm, O., Beutels, P., Bilcke, J., Brüggenjürgen, B., Gerber-Grote, A. U., Greiner, W., Hanquet, G., Harder, T., Hutubessy, R., Jit, M., Knol, M., Kuhlmann, A., Von Kries, R., Levy-Bruhl, D., Perleth, M., Postma, M. J., Salo, H., Siebert, U., ... Postma, M. (2014). Methods for health economic evaluations of vaccines-results from an international expert-workshop. Value in Health, 17(7), 552. https://doi.org/10.1016/j.jval.2014.08.1803

Pham, V. N. H., Hoang, T. M., & Postma, M. (2014). Pharmacoeconomic research and application in 10 Asian countries between 2003 and 2013: A systematic review. Value in Health, 17(7), 793. https://doi.org/10.1016/j.jval.2014.08.450

Postma, M., Thavorncharoensap, M., Riewpaiboon, A., & Thinyounyong, W. (2014). Quality of life of diarrheal children and caregivers in Thailand rochanathimokeo. Value in Health, 17(7), A368-A369. https://doi.org/10.1016/j.jval.2014.08.832

Treur, M., & Postma, M. (2014). Quasi-monte carlo simulation and variance reduction techniques substantially reduce computational requirements of patient-level simulation models: An application to a discrete event simulation model. Value in Health, 17(7), A326. https://doi.org/10.1016/j.jval.2014.08.585

Mihajlovic, J., Dolk, C., & Postma, M. (2014). Reimbursement of targeted cancer therapies within three different European health care systems. Value in Health, 17(7), A658-A659. https://doi.org/10.1016/j.jval.2014.08.2409

Crépey, P., De Boer, P., Postma, M. J., & Pitman, R. J. (2014). Retrospective public health impact of a quadrivalent influenza vaccine in the United States over the period 2000-2014. Value in Health, 17(7), 664-665. https://doi.org/10.1016/j.jval.2014.08.2446

Schlander, M., Garattini, S., Holm, S., Kolominsky-Rabas, P. L., Nord, E., Persson, U., Postma, M. J., Richardson, J., Simoens, S., De Sola-Morales, O., Tolley, K., & Toumi, M. (2014). The evaluation of economic methods to assess the social value of medical interventions for ultra-rare disorders (URDs). Value in Health, 17(7), A324. https://doi.org/10.1016/j.jval.2014.08.570

Smit, R., & Postma, M. J. (2014). Disability-adjusted life years (DALYs) as a composite measure to express the burden of tick-borne encephalitis (TBE) in Slovenia. Value in Health, 17(7), [A666]. https://doi.org/10.1016/j.jval.2014.08.2458

Stevanovic, J., Denee, L., Koenders, J. M., & Postma, M. J. (2014). Incidence description and costs of acute heart failure in the Netherlands. Value in Health, 17(7), A328-A328. https://doi.org/10.1016/j.jval.2014.08.597

Nguyen, T-P-L., Nguyen, T. B. Y., Nguyen, T. T., Vinh Hac, V., Le, H. H., Schuiling-Veninga, N., & Postma, M. J. (2014). Direct costs of hypertensive patients admitted to hospital in Vietnam: a bottom-up micro-costing analysis. BMC Health Services Research, 14, [514]. https://doi.org/10.1186/s12913-014-0514-4

van Boven, J. F. M., van Raaij, J. J., van der Galiën, R., Postma, M. J., van der Molen, T., Dekhuijzen, P. N. R., & Vegter, S. (2014). Impact of multiple-dose versus single-dose inhaler devices on COPD patients' persistence with long-acting beta(2)-agonists: A dispensing database analysis. npj Primary Care Respiratory Medicine, 24, [14069]. https://doi.org/10.1038/npjpcrm.2014.69

De Vries, D., Denig, P., Vegter, S., Bos, H. J., Postma, M. J., & Hak, E. (2014). Does a cardiovascular event change adherence to statin treatment in patients with type 2 diabetes? A matched cohort design. Pharmacoepidemiology and Drug Safety, 23(S1), 319-320. https://doi.org/10.1002/pds.3701

Standaert, B., Ethgen, O., Emerson, R., Postma, M., & Mauskopf, J. (2014). Comparing Cost-Effectiveness Results for a Vaccine Across Different Countries Worldwide: What Can We Learn? Advances in therapy, 31(10), 1095-1108. https://doi.org/10.1007/s12325-014-0160-6

Van Boven, J., Tommelein, E., Mehuys, E., Boussery, K., Vegter, S., Brusselle, G., Rutten-Van Mölken, M., & Postma, M. (2014). Therapietrouwbevordering COPD bespaart kosten. Pharmaceutisch Weekblad, 149(39), 20-21.

Bergmeijer, T. O., Janssen, P. W. A., Asselbergs, F. W., Schipper, J. C., Van 'T Hof, A. W., Dewilde, W. J. M., Postma, M. J., De Boer, A., Deneer, V. H. M., & Ten Berg, J. M. (2014). A tailored antiplatelet strategy in STEMI patients based on CYP2C19 genotyping is feasible in daily practice-POPular Genetics study. European Heart Journal, 35, 191-192. https://doi.org/10.1093/eurheartj/ehu323

van Boven, J. F., Tommelein, E., Boussery, K., Mehuys, E., Vegter, S., Brusselle, G. G., Rutten-van Mölken, M. P., & Postma, M. J. (2014). Optimalisation de la pharmacothérapie en pharmacie d'officine chez des patients atteints de Bronchopneumopathie Chronique Obstructive (BPCO): une analyse coût-efficacité. Journal de Pharmacie de Belgique, (3), 15-16.

Mafirakureva, N., Nyoni, H., Chikwereti, R., Khoza, S., Mvere, D. A., Emmanuel, J. C., Postma, M. J., & Van Hulst, M. (2014). The average unit production cost of blood in Zimbabwe from a provider's perspective. Transfusion, 54. https://doi.org/10.1111/trf.12845

Vegter, S., Oosterhof, P., Van Boven, J. F. M., Stuurman-Bieze, A. G. G., Hiddink, E., & Postma, M. J. (2014). Therapietrouwbevordering lipidenverlagers is kosteneffectief: Kosteneffectiviteit bij primaire, kostenbesparing bij secundaire preventie. Pharmaceutisch Weekblad, 149(35), 30-31.

Stevanovic, J., Pompen, M., Le, H. H., Rozenbaum, M. H., Tieleman, R. G., & Postma, M. J. (2014). Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands. PLoS ONE, 9(8), [e103974]. https://doi.org/10.1371/journal.pone.0103974

van Boven, J. F. M., Stuurman-Bieze, A. G. G., Hiddink, E. G., Postma, M. J., & Vegter, S. (2014). Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence. Journal of Managed Care Pharmacy, 20(8), 786-792. http://www.ncbi.nlm.nih.gov/pubmed/25062071

Schlander, M., Garattini, S., Holm, S., Kolominsky-Rabas, P., Nord, E., Persson, U., Postma, M., Richardson, J., Simoens, S., De Solà Morales, O., Tolley, K., & Toumi, M. (2014). Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders. Journal of Comparative Effectiveness Research, 3(4), 399-422. https://doi.org/10.2217/cer.14.34

Vemer, P., & Postma, M. J. (2014). A few years later: Update of the cost-effectiveness of infant pneumococcal vaccination in Dutch children. Human vaccines & immunotherapeutics, 10(7), 1841-1849. https://doi.org/10.4161/hv.29008

de Boer, P., Wilschut, J. C., & Postma, M. J. (2014). Cost-effectiveness of vaccination against herpes zoster. Human vaccines & immunotherapeutics, 10(7), 2048-2061. https://doi.org/10.4161/hv.28670

Bergmeijer, T. O., Janssen, P. W. A., Schipper, J. C., Qaderdan, K., Ishak, M., Ruitenbeek, R. S., Asselbergs, F. W., van 't Hof, A. W. J., Dewilde, W. J. M., Spanó, F., Herrman, J-P. R., Kelder, J. C., Postma, M. J., de Boer, A., Deneer, V. H. M., & ten Berg, J. M. (2014). CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study. American Heart Journal, 168(1), 16-22.e1. https://doi.org/10.1016/j.ahj.2014.03.006

Le, H. H., Hodgkins, P., Postma, M. J., Kahle, J., Sikirica, V., Setyawan, J., Erder, M. H., & Doshi, J. A. (2014). Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case. European Child & Adolescent Psychiatry, 23(7), 587-598. https://doi.org/10.1007/s00787-013-0477-8

Vegter, S., Oosterhof, P., van Boven, J. F. M., Stuurman-Bieze, A. G. G., Hiddink, E. G., & Postma, M. J. (2014). Improving adherence to lipid-lowering therapy in a community pharmacy intervention program: a cost-effectiveness analysis. Journal of Managed Care Pharmacy, 20(7), 722-732. https://doi.org/10.18553/jmcp.2014.20.7.722

Suwantika, A. A., Beutels, P., & Postma, M. J. (2014). Cost-effectiveness of hepatitis A vaccination in Indonesia. Human vaccines & immunotherapeutics, 10(8), 2342-2349. https://doi.org/10.4161/hv.29353

van Boven, J. F. M., Tommelein, E., Boussery, K., Mehuys, E., Vegter, S., Brusselle, G. G. O., Rutten-van Molken, M. P. M. H., & Postma, M. J. (2014). Improving inhaler adherence in patients with Chronic Obstructive Pulmonary Disease: A cost-effectiveness analysis. Respiratory Research, 15(1), [66]. https://doi.org/10.1186/1465-9921-15-66

Pitman, J. P., Wilkinson, R. L., Basavaraju, S. V., Von Finckenstein, B. G., Smit Sibinga, C. T. H., Marfin, A., Postma, M. J., Mataranyika, M. N., & Tobias, J. L. (2014). Investments in blood safety improve the availability of blood to underserved areas in a sub-saharan african country. Vox Sanguinis, 107(Supplement S1 (57-248)), 70-71. https://doi.org/10.1111/vox.12155

Radke, P. W., Halvorsen, S., Jukema, J. W., Kolh, P., Annemans, L., Postma, M. J., Ardissino, D., Kristensen, S. D., Bassand, J-P., Collet, J-P., Morais, J., Tuñón, J., & Halcox, J. (2014). Networks for improving care in patients with acute coronary syndrome: A framework. Acute Cardiac Care, 16(2), 41-48. https://doi.org/10.3109/17482941.2014.881502

Connolly, M. P., Kuyvenhoven, J. P., Postma, M. J., & Nielsen, S. K. (2014). Cost and quality-adjusted life year differences in the treatment of active ulcerative colitis using once-daily 4 g or twice-daily 2g mesalazine dosing. Journal of Crohn's and Colitis, 8(5), 357-362. https://doi.org/10.1016/j.crohns.2013.09.015

Van Boven, J. F., Tommelein, E., Boussery, K., Mehuys, E., Vegter, S., Brusselle, G. G., Rutten-Van Mölken, M. P. M. H., & Postma, M. J. (2014). Cost-effectiveness analysis of a pharmacist-led intervention on improving inhaler adherence in patients with chronic obstructive pulmonary disease. Value in Health, 17(3), A136. https://doi.org/10.1016/j.jval.2014.03.788

Mihajlović, J., & Postma, M. J. (2014). Cost-effectiveness of targeted therapeutics in metastatic renal cell cancer seen from two different economic perspectives. Value in Health, 17(3), A90. https://doi.org/10.1016/j.jval.2014.03.525

Nguyen, T. P. L., Schuiling-Veninga, N., Nguyen, T. B. Y., Hang, V. T. T., Wright, E. P., & Postma, M. J. (2014). Models to Predict the Burden of Cardiovascular Disease Risk in a Rural Mountainous Region of Vietnam. Value in Health Regional Issues, 3(1), 87-93. https://doi.org/10.1016/j.vhri.2014.03.003

Stevanovic, J., Pehlivanoglou, P., & Postma, M. J. (2014). Meta-analysis of preference-based quality of life values in heart failure. Value in Health, 17(3), A197-A197. https://doi.org/10.1016/j.jval.2014.03.1152

De Cao, E., Melegaro, A., Klok, R., & Postma, M. (2014). Optimising assessments of the epidemiological impact in the Netherlands of paediatric immunisation with 13-valent pneumococcal conjugate vaccine using dynamic transmission modelling. PLoS ONE, 9(4), [e89415]. https://doi.org/10.1371/journal.pone.0089415

Van Hasselt, F. M., Oud, M. J. T., Krabbe, P. F. M., Postma, M. J., & Loonen, A. J. M. (2014). Improving somatic health of outpatients with severe mental illness. Schizophrenia Research, 153(Supplement 1), S186-S187.

Suwantika, A. A., Zakiyah, N., Lestari, K., & Postma, M. J. (2014). Accelerating the introduction of rotavirus immunization in Indonesia. Expert review of vaccines, 13(4), 463-472. https://doi.org/10.1586/14760584.2014.891940

Parouty, M. B. Y., Le, H., Krooshof, D., & Postma, M. J. (2014). Differential time preferences for money and quality of life. Pharmacoeconomics, 32(4), 411-419. https://doi.org/10.1007/s40273-013-0124-8

Stevanovic, J., O'Prinsen, A. C., Verheggen, B. G., Schuiling-Veninga, N., Postma, M. J., & Pechlivanoglou, P. (2014). Economic Evaluation of Primary Prevention of Cardiovascular Diseases in Mild Hypertension: A Scenario Analysis for the Netherlands. Clinical Therapeutics, 36(3), 368-384. https://doi.org/10.1016/j.clinthera.2014.01.008

de Vries, F. M., Denig, P., Visser, S. T., Hak, E., & Postma, M. J. (2014). Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands. Value in Health, 17(2), 223-230. https://doi.org/10.1016/j.jval.2013.12.010

van Boven, J. F. M., Novak, A., Driessen, M. T., Boersma, C., Boomsma, M. M., & Postma, M. J. (2014). Economic Evaluation of Ropinirole Prolonged Release for Treatment of Parkinson’s Disease in The Netherlands. Drugs & Aging, 31(3), 193-201. https://doi.org/10.1007/s40266-013-0150-4

Moolenaar, L. M., Connolly, M., Huisman, B., Postma, M. J., Hompes, P. G. A., van der Veen, F., & Mol, B. W. J. (2014). Costs and benefits of individuals conceived after IVF: a net tax evaluation in The Netherlands. Reproductive Biomedicine Online, 28(2), 239-245. https://doi.org/10.1016/j.rbmo.2013.10.002

Standaert, B. A., Curran, D., & Postma, M. J. (2014). Budget constraint and vaccine dosing: A mathematical modelling exercise. Cost Effectiveness and Resource Allocation, 12(3), [3]. https://doi.org/10.1186/1478-7547-12-3

Huang, Y., Zhou, Q., Haaijer-Ruskamp, F. M., & Postma, M. J. (2014). Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review. Bmc nephrology, 15(1), [15]. https://doi.org/10.1186/1471-2369-15-15

Mafirakureva, N., Khoza, S., Mvere, D. A., Chitiyo, M. E., Postma, M. J., & Van Hulst, M. (2014). Incidence and pattern of 12 years of reported transfusion adverse events in Zimbabwe: A retrospective analysis. Blood transfusion, 12(3), 362-367. https://doi.org/10.2450/2014.0156-13

van Boven, J. F. M., Chavannes, N. H., van der Molen, T., Rutten-van Molken, M. P. M. H., Postma, M. J., & Vegter, S. (2014). Clinical and economic impact of non-adherence in COPD: A systematic review. Respiratory Medicine, 108(1), 103-113. https://doi.org/10.1016/j.rmed.2013.08.044

Parouty, M. B. Y., & Postma, M. J. (2014). A probabilistic theory for intertemporal indifference. Theoretical Economics Letters, 4(6), 415-424. [46834]. https://doi.org/10.4236/tel.2014.46053

Wouters, H., Quik, E. H., Boersma, F., Nygard, P., Bosman, J., Bottger, W. M., Mulder, H., Maring, J-G., Wijma-Vos, L., Beerden, T., van Doormaal, J., Postma, M. J., Zuidema, S. U., & Taxis, K. (2014). Discontinuing Inappropriate Medication in Nursing Home Residents (DIM-NHR Study): Protocol of a cluster randomised controlled trial. BMJ Open, 4(10), [e006082]. https://doi.org/10.1136/bmjopen-2014-006082